Friday, February 15, 2013

Breakthrough Insulin Pill Nearing Market

Israeli Company Begins Phase 2 Clinical Trials in US

Oramed Pharmaceutical's flagship product could revolutionize the treatment of diabetes, which affects more than 371 million people worldwide and is the seventh leading cause of death in the United States. Read more.